Inside Back Cover

Psoriasis is a chronic skin disease and the TNF-α is the therapeutic target of this disease. The experiments including SPR and in vivo tests discovered the ergosterols from the fungus Aspergillus sp. TJ507 serve as lead structures for the development of novel TNF-α inhibitory agents in the clinical treatment of psoriasis. More details are discussed in the article by Zhang et al. on page 743—751.